Nathaniel Calloway - 13 Jun 2024 Form 4 Insider Report for Anebulo Pharmaceuticals, Inc. (ANEB)

Role
Director
Signature
/s/ Nathaniel Calloway
Issuer symbol
ANEB
Transactions as of
13 Jun 2024
Net transactions value
$0
Form type
4
Filing time
17 Jun 2024, 16:23:52 UTC
Previous filing
02 Feb 2024
Next filing
10 Jul 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANEB Stock Option (right to buy) Award $0 +41,667 $0.000000 41,667 13 Jun 2024 Common Stock 41,667 $2.10 Direct F1
transaction ANEB Stock Option (right to buy) Award $0 +1,655 $0.000000 1,655 13 Jun 2024 Common Stock 1,655 $2.10 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These stock options vest 50% on the date of the 2024 annual meeting of shareholders and 50% on the one year anniversary of the date of grant
F2 These stock options vest on the earlier of November 30,2024 or the date of the 2024 annual meeting of shareholders

Remarks:

Exhibit List: Exhibit 24.1 - Power of Attorney (Nathaniel Calloway)